Literature DB >> 19494219

An autoinflammatory disease due to homozygous deletion of the IL1RN locus.

Sreelatha Reddy1, Shuang Jia, Rhonda Geoffrey, Rachel Lorier, Mariko Suchi, Ulrich Broeckel, Martin J Hessner, James Verbsky.   

Abstract

We describe a patient with an autoinflammatory disease in which the main clinical features are pustular rash, marked osteopenia, lytic bone lesions, respiratory insufficiency, and thrombosis. Genetic studies revealed a 175-kb homozygous deletion at chromosome 2q13, which encompasses several interleukin-1 family members, including the gene encoding the interleukin-1-receptor antagonist (IL1RN). Mononuclear cells, obtained from the patient and cultured, produced large amounts of inflammatory cytokines, with increasing amounts secreted after stimulation with lipopolysaccharide. A similar increase was not observed in peripheral-blood mononuclear cells from a patient with neonatal-onset multisystem inflammatory disorder (NOMID). Treatment with anakinra completely resolved the symptoms and lesions. 2009 Massachusetts Medical Society

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19494219      PMCID: PMC2803085          DOI: 10.1056/NEJMoa0809568

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  21 in total

1.  Human T regulatory cells can use the perforin pathway to cause autologous target cell death.

Authors:  William J Grossman; James W Verbsky; Winfried Barchet; Marco Colonna; John P Atkinson; Timothy J Ley
Journal:  Immunity       Date:  2004-10       Impact factor: 31.745

2.  Psoriasis-like cutaneous inflammation in mice lacking interleukin-1 receptor antagonist.

Authors:  Joanna Shepherd; Matthew C Little; Martin J H Nicklin
Journal:  J Invest Dermatol       Date:  2004-03       Impact factor: 8.551

3.  Arthropathy with rash, chronic meningitis, eye lesions, and mental retardation.

Authors:  A M Prieur; C Griscelli
Journal:  J Pediatr       Date:  1981-07       Impact factor: 4.406

4.  Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs.

Authors:  Jennifer E Towne; Kirsten E Garka; Blair R Renshaw; G Duke Virca; John E Sims
Journal:  J Biol Chem       Date:  2004-01-20       Impact factor: 5.157

5.  Disease-associated CIAS1 mutations induce monocyte death, revealing low-level mosaicism in mutation-negative cryopyrin-associated periodic syndrome patients.

Authors:  Megumu Saito; Ryuta Nishikomori; Naotomo Kambe; Akihiro Fujisawa; Hideaki Tanizaki; Kyoko Takeichi; Tomoyuki Imagawa; Tomoko Iehara; Hidetoshi Takada; Tadashi Matsubayashi; Hiroshi Tanaka; Hisashi Kawashima; Kiyoshi Kawakami; Shinji Kagami; Ikuo Okafuji; Takakazu Yoshioka; Souichi Adachi; Toshio Heike; Yoshiki Miyachi; Tatsutoshi Nakahata
Journal:  Blood       Date:  2007-12-06       Impact factor: 22.113

6.  A chronic, infantile, neurological, cutaneous and articular (CINCA) syndrome. A specific entity analysed in 30 patients.

Authors:  A M Prieur; C Griscelli; F Lampert; H Truckenbrodt; M A Guggenheim; D J Lovell; P Pelkonnen; J Chevrant-Breton; B M Ansell
Journal:  Scand J Rheumatol Suppl       Date:  1987

Review 7.  The role of interleukin-1 in bone resorption in rheumatoid arthritis.

Authors:  V Strand; A F Kavanaugh
Journal:  Rheumatology (Oxford)       Date:  2004-06       Impact factor: 7.580

Review 8.  Inflammation in pregnancy: its roles in reproductive physiology, obstetrical complications, and fetal injury.

Authors:  Roberto Romero; Francesca Gotsch; Beth Pineles; Juan Pedro Kusanovic
Journal:  Nutr Rev       Date:  2007-12       Impact factor: 7.110

9.  NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder.

Authors:  Laetitia Agostini; Fabio Martinon; Kimberly Burns; Michael F McDermott; Philip N Hawkins; Jürg Tschopp
Journal:  Immunity       Date:  2004-03       Impact factor: 31.745

10.  Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation.

Authors:  Hal Blumberg; Huyen Dinh; Esther S Trueblood; James Pretorius; David Kugler; Ning Weng; Suzanne T Kanaly; Jennifer E Towne; Cynthia R Willis; Melanie K Kuechle; John E Sims; Jacques J Peschon
Journal:  J Exp Med       Date:  2007-10-01       Impact factor: 14.307

View more
  141 in total

1.  Impact of IL-1 signalling on experimental uveitis and arthritis.

Authors:  Stephen R Planck; April Woods; Jenna S Clowers; Martin J Nicklin; James T Rosenbaum; Holly L Rosenzweig
Journal:  Ann Rheum Dis       Date:  2012-01-20       Impact factor: 19.103

Review 2.  Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.

Authors:  Kristina Ludigs; Valeriy Parfenov; Renaud A Du Pasquier; Greta Guarda
Journal:  Cell Mol Life Sci       Date:  2012-04-24       Impact factor: 9.261

3.  DIRA, DITRA, and new insights into pathways of skin inflammation: what's in a name?

Authors:  Edward W Cowen; Raphaela Goldbach-Mansky
Journal:  Arch Dermatol       Date:  2012-03

4.  Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis.

Authors:  Alexandros Onoufriadis; Michael A Simpson; Andrew E Pink; Paola Di Meglio; Catherine H Smith; Venu Pullabhatla; Jo Knight; Sarah L Spain; Frank O Nestle; A David Burden; Francesca Capon; Richard C Trembath; Jonathan N Barker
Journal:  Am J Hum Genet       Date:  2011-08-11       Impact factor: 11.025

Review 5.  Genetically defined autoinflammatory diseases.

Authors:  A A de Jesus; R Goldbach-Mansky
Journal:  Oral Dis       Date:  2016-04-14       Impact factor: 3.511

Review 6.  The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation.

Authors:  Kalpana Manthiram; Qing Zhou; Ivona Aksentijevich; Daniel L Kastner
Journal:  Nat Immunol       Date:  2017-07-19       Impact factor: 25.606

Review 7.  After GWAS: mice to the rescue?

Authors:  Joerg Ermann; Laurie H Glimcher
Journal:  Curr Opin Immunol       Date:  2012-09-29       Impact factor: 7.486

8.  Impaired cytokine responses in patients with cryopyrin-associated periodic syndrome (CAPS).

Authors:  M H Haverkamp; E van de Vosse; R Goldbach-Mansky; S M Holland
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

Review 9.  Autoinflammation: the prominent role of IL-1 in monogenic autoinflammatory diseases and implications for common illnesses.

Authors:  Raphaela Goldbach-Mansky; Daniel L Kastner
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

Review 10.  Therapy of autoinflammatory syndromes.

Authors:  Hal M Hoffman
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.